SH2D1A
SH2D1A[edit | edit source]
SH2D1A (SH2 domain-containing protein 1A), also known as SLAM-associated protein (SAP), is a protein encoded by the SH2D1A gene in humans. This protein plays a crucial role in the immune system, particularly in the signaling pathways of T cells and natural killer (NK) cells.
Structure[edit | edit source]
SH2D1A is a small protein consisting of 128 amino acids. It contains a single SH2 (Src homology 2) domain, which is responsible for binding to phosphorylated tyrosine residues on other proteins. This domain is critical for its role in signal transduction.
Function[edit | edit source]
SH2D1A is primarily expressed in T cells and NK cells. It is involved in the regulation of immune responses by interacting with members of the SLAM (Signaling Lymphocytic Activation Molecule) family of receptors. These interactions are important for the activation and proliferation of T cells and NK cells, as well as for the regulation of cytokine production.
The protein acts as an adaptor, linking SLAM family receptors to downstream signaling pathways. It is essential for the proper functioning of the immune system, particularly in the context of viral infections and immune surveillance.
Clinical Significance[edit | edit source]
Mutations in the SH2D1A gene are associated with X-linked lymphoproliferative disease (XLP), also known as Duncan's disease. This rare genetic disorder is characterized by an abnormal immune response to Epstein-Barr virus (EBV) infection, leading to severe and often fatal complications such as fulminant infectious mononucleosis, lymphoma, and dysgammaglobulinemia.
Patients with XLP have a defective SH2D1A protein, which impairs the normal signaling pathways in T cells and NK cells, resulting in an inability to control EBV infections effectively.
Research and Therapeutic Implications[edit | edit source]
Understanding the role of SH2D1A in immune signaling has implications for the development of therapies for XLP and other immune-related disorders. Gene therapy and targeted molecular therapies are areas of active research, aiming to correct the underlying genetic defect or modulate the signaling pathways affected by SH2D1A dysfunction.
Also see[edit | edit source]
- X-linked lymphoproliferative disease
- SLAM family receptors
- T cell signaling
- Natural killer cell
- Epstein-Barr virus
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
